Medtronic (Minneapolis) has received FDA approval to sell its Endurant AAA stent graft system in the U.S. for the minimally invasive treatment of AAA, a largely unknown and often fatal condition. (Medical Device Daily) Read More
HeartWare (Framingham, Massachusetts) is in an even better position to begin a robust build-out of its U.S. sales and support infrastructure after having recently completed a $125 million convertible note transaction, according to Canaccord Genuity (Toronto) analyst Jason Mills. (Medical Device Daily)
Read More
